Vaxart (VXRT) Director James B. Breitmeyer Receives Stock Awards

What Happened
James B. Breitmeyer, a director of Vaxart, was granted 8,315 shares and a derivative award for 16,610 shares on July 16, 2026. Both entries are reported as acquisitions at $0.00 (no cash paid). The awards are subject to vesting rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-16; filing date: 2026-07-17 (timely).
• Price: $0.00 for both awards (compensation grants, not purchases).
• Shares reported: 8,315 shares (restricted stock units) and 16,610 shares (derivative award).
• Vesting: Both awards vest on the earlier of the date immediately prior to the 2027 annual meeting of stockholders and July 16, 2027 (first anniversary of the grant). (See footnotes F1 and F2.)
• Shares owned after transaction: Not specified in the provided filing.
• Filing status: Timely (no late-file indication).

Context
These are compensation awards (RSUs/derivative grant) that create the right to receive shares in the future if vesting conditions are met. They do not reflect an immediate purchase or sale and are common for board compensation; they may dilute outstanding shares if and when they vest.